Evaluation of carcinogenic responses in the Eker rat following short-term exposure to selected nephrotoxins and carcinogens

Toxicologic Pathology

Volumn 30, Issue 5, 2002, Pages 559-564

  Morton, Laura Dill ^a   Youssef, Ashraf F ^a   Lloyd, Eric ^a   Kiorpes, Anthony L ^a   Goldsworthy, Thomas L ^a   Fort, Farrell L ^a  

^a PFIZER INC   (United States)

Author keywords

Alternative model; Bioassay; Carcinogenesis; Eker; Rat

Indexed keywords

CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARCINOGENICITY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; EVALUATION; GENOTOXICITY; IMMUNE RESPONSE; MALIGNANT TRANSFORMATION; MEMBRANE VESICLE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIATION EXPOSURE; RAT; SAFETY;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOGENICITY TESTS; CARCINOGENS; CYCLOSPORINE; FURANS; INJECTIONS, INTRAPERITONEAL; KIDNEY NEOPLASMS; MALE; MUTAGENS; NITRILOTRIACETIC ACID; NITROPARAFFINS; PHENYLENEDIAMINES; PRECANCEROUS CONDITIONS; PROPANE; RATS; RATS, INBRED STRAINS;

ANIMALIA;

EID: 0036742905     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230290105794     Document Type: Article

References (23)

1. Crino PB, Henske EP (1999). New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53: 1384-1390.
2. European Chromosome 16 Tuberous Sclerosis Consortium (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305-1315.
3. Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1992). Hereditary renal cell carcinoma in the Eker model: A rodent cancer syndrome with similarities to von-Hippel-Lindau disease. J Urol 148: 1932-1936.
4. Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1995). Hereditary renal carcinoma in the Eker rat: A unique animal model for the study of cancer susceptibility. Toxicol Lett 82/83: 621-625.
5. Green AJ, Smith M, Yates JRW (1994). Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Gen 6: 193-196.
6. Hino O, Klein-Szanto AJP, Freed JJ, Testa JR, Brown DQ, Vilensky M, Yeung RS, Tartof KD, Knudson AG (1993). Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci USA 90: 327-331.
7. Hino O, Kobayashi T, Mitani H, Kobayashi E, Kubo Y, Tsuchiya H, Kekuchi Y, Nishizawa M, Hirayama Y (1995). The Eker rat, a model of dominantly inherited cancer syndrome. Transplant Proc 27: 1529-1531.
8. Hino O, Kobayashi T, Tsuchiya H, Kikuchi Y, Kobayashi E, Mitani H, Hirayama Y (1994). The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (Tsc2) gene. Biochem Biophys Res Comm 203: 1302-1308.
9. Hino O, Mitani H, Knudson AG (1993). Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res 53: 5856-5858.
10. International Conference on Harmonisation (1998). Guidance on testing for carcinogenicity of pharmaceuticals. Fed Regist 63: 8963-8986.
11. Kobayashi T, Urakami S, Hirayama Y, Yamamoto T, Nishizawa M, Takahara T, Kubo Y, Hino O (1997). Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn J Cancer Res 88: 254-261.
12. Kubo Y, Kikuchi Y, Mitani H, Kobayashi E, Kobayashi T, Hino O (1995). Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model. Jpn J Canc Res 86: 828-832.
13. Lau SS, Monks TJ, Everitt JI, Kleymenova E, Walker CW (2001). Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. Chem Res Toxicol 14: 25-33.
14. Maronpot RR, Giles HD, Dykes DJ, Irwin RD (1991). Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 19: 561-569.
15. Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland MW, Halley DJJ, van der Sluijs P (1999). Characterization of the cytosolic tuberin-hamartin complex. J Biol Chem 50: 35647-35652.
16. Tennant RW, Spalding J, French JE (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutation Res 365:119-127.
17. Van Slegtenhorst MA, de Hoogt R, Hermans C, Nellist M, Janssen B, Verboef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808.
18. Walker CL, Goldsworthy TL, Wolf DC, Everitt JI (1992). Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science 255: 1693-1695.
19. Wolf DC, Goldsworthy TL, Donner EM, Harden R, Fitzpatrick B, Everitt JI (1998). Estrogen treatment enhances hereditary renal tumor development in Eker rats. Carcinogenesis 19: 2043-2947.
20. Xiao G-H, Yeung RS (1995) Germ-line Tsc2 mutation in a dominantly inherited cancer model defines a novel family of rat intracisternal-A particle elements. Oncogene 11: 81-87.
21. Yeung RS, Guang-Hui X, Everitt JI, Jin F, Walker CL (1995). Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol Carcinogen 14: 28-36.
22. Yeung RS, Guang-Hui X, Jin F, Lee W-C, Testa JR, Knudson AG (1994). Predisposition for renal carcinoma in the Eker rat is determined by germline mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 91: 11413-11416.
23. Yeung RS, Katsetos CD, Klein-Szanto A (1997). Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151: 1477-1486.